RSS Feeds | Back To School In A Healthy Way
August 30, 2007 07:00:00Anthem Blue Cross and Blue Shield in Ohio is reminding parents to make sure their kids immunizations are up-to- date as part of their back to school preparations. In 2006 more than half of Ohio adolescents were not immunized against potentially dangerous viral diseases, including Hepatitis B, Measles, Mumps, Rubella and Chicken Pox, according to the 2006 report from the Health Plan Employer Data Information Set (HEDIS(R)). [click link for full article] - [Read more] |
| Immunizations Part Of Back To School Preparations
August 29, 2007 07:00:00In recognition of National Immunization Awareness Month, Anthem Blue Cross and Blue Shield in Connecticut is reminding parents to make sure their adolescents immunizations are up to date as part of their back to school preparations. August is the perfect time for parents to check with their childs provider to be certain they are current on their vaccines. [click link for full article] - [Read more] |
| Vical Begins Phase 1 Trial Of DNA Vaccine Against H5N1 Pandemic Influenza
August 29, 2007 07:00:00Vical Incorporated (Nasdaq: VICL) announced the enrollment of the first subject in its Phase 1 trial of the companys Vaxfectin(TM)-formulated plasmid DNA (pDNA) pandemic influenza vaccine. The double-blind, placebo-controlled trial will evaluate safety, tolerability and immune responses in up to 60 healthy volunteers age 18 to 45 at two U.S. clinical sites. [click link for full article] - [Read more] |
| The Immune Systems Link To Anthrax
August 28, 2007 08:00:00Human immune proteins crucial for fighting cancer, viruses and bacterial infections belong to an ancient and lethal toxin family previously only found in bacteria, Australian researchers have found.These proteins, called perforins, are related to bacterial toxins that cause diseases such as anthrax, gas gangrene and scarlet fever. The discovery was made by a team led by Professor James Whisstock and Dr Michelle Dunstone from Monash Universitys School of Biomedical Sciences. [click link for full article] - [Read more] |
| New Data Redefining Laboratory Reference Ranges In Africa Released By IAVI, CDC And USMHRP
August 25, 2007 03:00:00Leading researchers from the International AIDS Vaccine Initiative (IAVI), the U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Military HIV Research Program (USMHRP) have presented final results from a collection of independent studies reexamining the medical criteria for including African volunteers in AIDS vaccine trials. [click link for full article] - [Read more] |
| AVAC Releases 2007 Report On AIDS Vaccine Research, Development
August 24, 2007 18:00:00"Resetting the Clock," AIDS Vaccine Advocacy Coalition: The 2007 AVAC reports three sections outlined specific deadlines and obstacles in AIDS vaccine development strategies, clinical trials and the broader field of HIV prevention. [click link for full article] - [Read more] |
| Bioniche Ships First Order Of E. Coli O157:H7 Cattle Vaccine
August 24, 2007 07:00:00Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology driven Canadian biopharmaceutical company, announced that the first permit has been issued for its E. coli O157:H7 cattle vaccine ("the vaccine"), and that the first order of vaccine has been shipped to that customer. The vaccine will be used for the reduction of shedding of E. coli O157:H7 bacteria in cattle. Shed bacteria can contaminate food, water and the environment. [click link for full article] - [Read more] |
| Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
August 23, 2007 07:00:00Vical Incorporated (Nasdaq: VICL) announced today that results from a series of HIV vaccine Phase 2a clinical trials, using a plasmid DNA (pDNA) vaccine developed by the NIH Vaccine Research Center and manufactured by Vical, reinforced previously reported Phase 1 conclusions that a "DNA prime-adenoviral vector boost" vaccine regimen was safe and well-tolerated, and was effective in inducing T-cell immune responses in up to 70% of the vaccine recipients. [click link for full article] - [Read more] |
| APhA Publishes New Vaccine Bulletin - Research Finds That Vaccine May Help To Prevent Pertussis
August 22, 2007 08:00:00As summer comes to a close, many parents are preparing their children to return to school. Any back to school plan will probably include a trip to the doctor or the neighborhood pharmacist to receive vaccinations. While children are commonly vaccinated to protect against chicken pox, measles and polio , one health threat often overlooked is pertussis. The spread of pertussis, also known as the "whooping cough", declined after widespread use of the vaccine began during the 1940s. [click link for full article] - [Read more] |
| Need A Flu Shot Reminder?
August 22, 2007 07:00:00With summer vacation coming to an end, flu season is just around the corner. Hectic back-to-school and work schedules are sure to cause some to forget that they need to schedule a flu shot. Whether you are scheduling the flu vaccination for an elderly parent, child or yourself, you can sign up to receive an e mail to remind you to get your flu shot. Simply log on to http://www.FindaFluShot. [click link for full article] - [Read more] |
| Global Experts Explore Entire Spectrum Of Aids Vaccine Development
August 21, 2007 07:00:00More than 900 global researchers, clinicians, and specialists convene this week for the AIDS Vaccine 2007 Conference at the Sheraton Seattle Hotel and Towers. Since the AIDS Vaccine 2000 Conference in Paris, this event has emerged as the premier forum for the exchange of scientific information relating to the difficult task of developing an effective vaccine against HIV. [click link for full article] - [Read more] |
| Enzyme Used By Tumors To Recruit Regulatory T-Cells And Suppress Immune Response
August 20, 2007 15:00:00One way tumors fly under the radar of the immune system is by using IDO, an enzyme used by fetuses to help avoid rejection, to recruit powerful regulatory T cells that turn down the immune response, researchers say.It was known tumors assemble a protective barrier of regulatory T cells, or Tregs, but how they are such able recruiters was an unknown, says Dr. David Munn, pediatric hematologist/oncologist at the Medical College of Georgia Cancer Center. [click link for full article] - [Read more] |
| GlaxoSmithKline Signs Contract For Its Pandemic Flu Vaccine With UK Government
August 20, 2007 07:00:00GlaxoSmithKline (GSK) announced that it has entered into an agreement with the UK Government to provide its pandemic influenza vaccine in the event of a flu pandemic. It is one of the largest contracts signed by GSK to date for its proprietary adjuvanted pandemic flu vaccine.As part of an Advance Supply Agreement, GSK has committed to make the necessary preparations to supply its pandemic influenza vaccine as soon as possible after a pandemic outbreak has been declared. [click link for full article] - [Read more] |
| Results Published On BHT-3009, Experimental DNA Vaccine Treatment For MS
August 19, 2007 08:00:00An early-phase study of BHT-3009 (Bayhill Therapeutics), both alone and in combination with Lipitor® (atorvastatin, Pfizer, Inc.) found the drug to be safe and to induce a beneficial immune response in relapsing-remitting+ or secondary-progressive MS**. BHT-3009 is a vaccine containing genetic material that instructs cells to produce myelin basic protein (MBP), a component of myelin, an immune target in MS. [click link for full article] - [Read more] |
| Government Announces Advanced Supply Contracts For Pandemic Flu Vaccine, UK
August 18, 2007 08:00:00Advanced supply contracts to provide the vaccine for a possible flu pandemic were awarded by the Department of Health to pharmaceutical company GSK and Baxter Healthcare. The contracts, worth Ă‚Â£155.4 million over four years, are part of the Governments continued work to prepare for and reduce the impact of a possible flu pandemic. [click link for full article] - [Read more] |
|
|
